Comparative Risk of Thrombotic and Cardiovascular Events with Tofacitinib and Anti-TNF Agents in Patients with Inflammatory Bowel Diseases
Bharati Kochar, David Cheng, Tianxi Cai, Ashwin N. Ananthakrishnan
Topics & Concepts
TofacitinibMedicineInternal medicineHazard ratioInflammatory bowel diseaseHepatologyCohortAdalimumabRetrospective cohort studyCohort studyRheumatoid arthritisGastroenterologyDiseaseConfidence intervalInflammatory Bowel DiseaseRheumatoid Arthritis Research and TherapiesPlatelet Disorders and Treatments